This NDC is on FDA's drug shortage list (posted Jul 18, 2023)
Product Information
LIRAGLUTIDE 2-PAK 18 MG/3 ML is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $33.8176 per ML under NDC 00480366720. Its NADAC has been published 101 times since Sep 18, 2024.
FDA first approved this application on Jan 25, 2010. Its Orange Book therapeutic-equivalence code is AP1.
Strength
6 mg/mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480366720
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
LIRAGLUTIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022341FDA Approved
1/25/2010
TE Code
AP1
On Market Since
6/24/2024
Pharmacological Classes
Price Statistics
The NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has been published 101 times since Sep 18, 2024, and over the history we have for it it has declined 54.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $33.8176 per ML |
|---|---|
| All-time high | $74.4400 (Oct 16, 2024) |
| All-time low | $33.8176 (Aug 19, 2026) |
| 52-week high | $65.6636 |
| 52-week low | $33.8176 |
| Median price | $64.2171 |
| Average price | $58.9000 |
| Largest weekly change | -11.1% (Apr 22, 2026) |
| Weeks tracked | 101 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LIRAGLUTIDE 2-PAK 18 MG/3 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 2-PAK 18 MG/3 ML, manufactured by Teva Pharmaceuticals USA Inc., is $33.8176 per ML (NDC 00480366720), effective Aug 19, 2026.
How has the price of LIRAGLUTIDE 2-PAK 18 MG/3 ML changed over time?
Over the history we have for it, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has declined 54.6%. It has been tracked across 101 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 2-PAK 18 MG/3 ML?
Since Sep 18, 2024, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has ranged from a low of $33.8176 (Aug 19, 2026) to a high of $74.4400 (Oct 16, 2024), with a median of $64.2171 per ML.
Are there cheaper alternatives to LIRAGLUTIDE 2-PAK 18 MG/3 ML?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $32.0017 per ML — about 5% below LIRAGLUTIDE 2-PAK 18 MG/3 ML.
Who manufactures LIRAGLUTIDE 2-PAK 18 MG/3 ML?
LIRAGLUTIDE 2-PAK 18 MG/3 ML (NDC 00480366720) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is LIRAGLUTIDE 2-PAK 18 MG/3 ML in shortage?
Yes — NDC 00480366720 is currently listed in FDA's drug shortage database (posted Jul 18, 2023).